CASI Pharmaceuticals

About:

CASI focus on building a pipeline through mutually beneficial business development transactions.

Website: http://www.casipharmaceuticals.com/

Top Investors: GE Healthcare, Accel, Foresite Capital, IDG Capital, Venrock Healthcare Capital Partners

Description:

CASI Pharmaceuticals, Inc. ("CASI", "we" or "us") is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. CASI is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. CASI is executing its plan to become a biopharmaceutical leader by launching medicines in the greater China market leveraging CASI's China-based regulatory and commercial competencies and its global drug development expertise.